Good morning, everyone. Damian Garde here, filling in for Ed Silverman at the start of yet another working week. The holidays are just within sight, beyond the routine of deadlines, and meetings, and internal debates over whether it’s OK to leave your camera off this one time. Here to get your week in motion is that regular menu of tidbits. And, as always, if you hear anything interesting out there, please let us know. …
An expert committee that advises the Centers for Disease Control and Prevention on vaccines voted unanimously to recommend Covid-19 booster-shot eligibility be thrown open to all adults 18 and older, STAT informs us. The group also voted to lower the age for adults who should be urged to get a booster. CDC Director Rochelle Walensky quickly signed off on the changes.
A pair of European investment groups are considering a joint offer for Sandoz, Novartis’s (NVS) generics business, Reuters reports. The offer, from EQT and the Struengmann family office, would value Sandoz at about $20 billion. Novartis has said it is considering all options for Sandoz, including selling the division and spinning it out as an independent business.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
